skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
organooxygen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > fucosyl oligoglycosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer

Preferred term

beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

charge

  • 0

formula

  • C50H83N3O37R2

mass

  • 1318.194

monoisotopicmass

  • 1317.47054

smiles

  • [C@H]1(O[C@@H]([C@H](O)[C@@H]([C@H]1O)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2NC(C)=O)O[C@@H]3O[C@H]([C@H]([C@H]([C@@H]3O)O)O)C)O[C@@H]4O[C@@H]([C@H](O)[C@@H]([C@H]4O)O)CO)CO)O[C@H]5[C@@H]([C@@H](NC(C)=O)[C@H](O[C@@H]6[C@H]([C@H](O[C@H]7[C@@H]([C@H]([C@H](OC[C@@H]([C@@H](*)O)NC(*)=O)O[C@@H]7CO)O)O)O[C@@H]([C@@H]6O)CO)O)O[C@@H]5CO)O

subset

  • 3_STAR

synonym EXACT

  • beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:90360

Download this concept: